Company
Date
Role
Action
Shares
Amount
Of holding
22 May 2026
Director
Sold on a plan
5,682
$2.93M
20.5%
13 Nov 2025
Director
Sold on a plan
8,500
$4.43M
28.6%
14 May 2025
Director
Bought
20,000
$63.80K
64.5%
7 Nov 2024
Director
Sold on a plan
5,000
$1.75M
31.2%
1 Nov 2024
Director
Sold on a plan
5,000
$1.50M
31.2%
1 Apr 2024
Director
Sold on a plan
11,000
$2.83M
51.6%
17 Jan 2023
Director
Sold, plan not stated
22,489
$6.59M
71.2%
20 Mar 2020
Director
Bought
1,000
$44.33K
opened
23 Aug 2017
Director
Bought
2,000
$32.24K
28.2%
22 Aug 2017
Director
Bought
3,550
$57.21K
100%
21 Aug 2017
Director
Bought
3,550
$56.36K
opened
6 Jan 2016
EVP, Chief Drug Dev Officer
Sold, plan not stated
3,937
$401.02K
18.9%
7 Dec 2015
EVP, Chief Drug Dev Officer
Sold, plan not stated
3,937
$418.03K
18.9%
6 Nov 2015
EVP, Chief Drug Dev Officer
Sold, plan not stated
3,936
$458.58K
18.9%
6 Oct 2015
EVP, Chief Drug Dev Officer
Sold, plan not stated
3,937
$481.46K
18.9%
11 Sep 2015
EVP, Chief Drug Dev Officer
Sold, plan not stated
4,301
$559.13K
20.3%
8 Sep 2015
EVP, Chief Drug Dev Officer
Sold, plan not stated
3,937
$468.11K
15.6%
6 Aug 2015
EVP, Chief Drug Dev Officer
Sold, plan not stated
3,936
$440.64K
15.6%
15 Jul 2015
EVP, Chief Drug Dev Officer
Sold, plan not stated
70,217
$8.43M
76.8%
6 Jul 2015
EVP, Chief Drug Dev Officer
Sold, plan not stated
3,937
$421.26K
15.6%
19 Jun 2015
EVP, Chief Drug Dev Officer
Sold, plan not stated
20,000
$2.16M
48.5%
8 Jun 2015
EVP, Chief Drug Dev Officer
Sold, plan not stated
3,937
$423.54K
15.6%
6 May 2015
EVP, Chief Drug Dev Officer
Sold, plan not stated
7,412
$736.98K
25.9%
6 Apr 2015
EVP, Chief Drug Dev Officer
Sold, plan not stated
25,000
$2.22M
54.1%
6 Mar 2015
EVP, Chief Drug Dev Officer
Sold, plan not stated
25,000
$2.25M
54.1%
17 Feb 2015
EVP, Chief Drug Dev&Medical Of
Sold, plan not stated
12,000
$922.80K
39.7%
6 Feb 2015
EVP, Chief Drug Dev&Medical Of
Sold, plan not stated
25,000
$1.88M
57.9%
16 Jan 2015
EVP, Chief Drug Dev&Medical Of
Sold, plan not stated
12,000
$876.84K
39.7%
6 Jan 2015
EVP, Chief Drug Dev&Medical Of
Sold, plan not stated
25,000
$1.80M
57.9%
16 Dec 2014
EVP, Chief Drug Dev&Medical Of
Sold, plan not stated
12,000
$868.32K
39.7%
17 Nov 2014
EVP, Chief Drug Dev&Medical Of
Sold, plan not stated
12,000
$839.64K
39.7%
16 Oct 2014
EVP, Chief Drug Dev&Medical Of
Sold, plan not stated
8,000
$392.24K
65.0%
16 Sep 2014
EVP, Chief Drug Dev&Medical Of
Sold, plan not stated
8,000
$380.64K
65.0%
18 Aug 2014
EVP, Chief Drug Dev&Medical Of
Sold, plan not stated
8,000
$415.76K
65.0%
16 Jul 2014
EVP, Chief Drug Dev&Medical Of
Sold, plan not stated
8,000
$385.20K
65.0%
16 Jun 2014
EVP, Chief Drug Dev&Medical Of
Sold, plan not stated
8,000
$431.04K
65.0%
16 May 2014
EVP, Chief Drug Dev&Medical Of
Sold, plan not stated
8,000
$405.44K
65.0%
14 Feb 2014
EVP, Chief Drug Dev&Medical Of
Sold, plan not stated
39,787
$2.63M
90.2%
13 Feb 2014
EVP, Chief Drug Dev&Medical Of
Sold, plan not stated
191,309
$12.70M
97.8%
6 Sep 2013
EVP, Chief Drug Dev&Medical Of
Sold, plan not stated
25,000
$882.00K
100%
13 May 2013
EVP, Chief Drug Dev&Medical Of
Sold, plan not stated
55,699
$1.24M
92.8%
15 Feb 2013
EVP, Chief Drug Dev&Medical Of
Sold, plan not stated
98,440
$2.21M
100%
27 Apr 2012
EVP, Chief Drug Dev&Medical Of
Sold, plan not stated
30,000
$688.50K
100%
18 Jan 2011
EVP, Chief Drug Dev&Medical Of
Sold, plan not stated
40,310
$636.85K
100%
15 Mar 2010
EVP, Chief Drug Dev&Medical Of
Sold, plan not stated
20,000
$258.80K
100%
